Heart failure with preserved ejection fraction: a nephrologist-directed primer

Heart Failure Reviews
Baris AfsarMehmet Kanbay

Abstract

There is substantial causal and consequential interaction between the ever-growing heart failure and renal failure patients. Half of the patients with heart failure (HF) have preserved left ventricular ejection fraction (HFpEF), which is difficult to diagnose and rising in prevalence relative to HF with reduced EF (HFpEF). To date, only weight reduction, exercise training, and diuretics have been shown to improve exercise tolerance and morbidity in HFpEF. This review aims to establish the baseline kidney-related concepts specific to the diagnosis and treatment of HFpEF patients and the different aspects of HFpEF and HFpEF in the clinical setting.

References

Oct 3, 2002·Seminars in Dialysis·Peter Stenvinkel, Anders Alvestrand
Oct 24, 2002·Journal of Molecular and Cellular Cardiology·Ralica PetrovaHiroshi Yamamoto
Dec 11, 2002·Circulation·Donald M Lloyd-JonesUNKNOWN Framingham Heart Study
Apr 16, 2003·Kidney International. Supplement·Jan GalleChristoph Wanner
May 29, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jasper W L HartogPaul E de Jong
Apr 14, 2006·Kidney International·H YamamotoE Kusano
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Jul 21, 2006·The New England Journal of Medicine·R Sacha BhatiaPeter P Liu
Feb 13, 2007·Journal of the American College of Cardiology·Maria Rosa CostanzoUNKNOWN UNLOAD Trial Investigators
Oct 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Hans OberleithnerMartin Hausberg
Nov 21, 2007·European Journal of Heart Failure·Jasper W L HartogDirk J van Veldhuisen
Jan 18, 2008·Journal of the American Society of Nephrology : JASN·Mahmut Ilker YilmazJonas Axelsson
Jan 19, 2008·The American Journal of Pathology·Neil C HendersonTariq Sethi
Feb 1, 2008·Heart Failure Reviews·Inder S Anand
Mar 4, 2008·Heart Failure Clinics·Barry A Borlaug, David A Kass
Mar 7, 2008·Antioxidants & Redox Signaling·Eberhard SchulzThomas Münzel
Apr 4, 2008·American Journal of Physiology. Renal Physiology·G S Di MarcoH Pavenstädt
Nov 13, 2008·The New England Journal of Medicine·Barry M MassieUNKNOWN I-PRESERVE Investigators
Mar 7, 2009·Current Heart Failure Reports·Travis BenchMathew S Maurer
Nov 10, 2009·International Journal of Cardiology·Dan RusinaruChristophe Tribouilloy
Jan 20, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kim E JieMarianne C Verhaar
May 8, 2010·Journal of the American College of Cardiology·Andreas KalogeropoulosUNKNOWN Health ABC Study Investigators
Aug 6, 2010·European Journal of Heart Failure·Carolyn S P LamRamachandran S Vasan
Mar 23, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pierre Vladimir EnnezatThierry H Le Jemtel
Apr 9, 2011·Journal of Cachexia, Sarcopenia and Muscle·Stephan von Haehling, Stefan D Anker
Oct 11, 2011·Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır·Ozlem KarakurtRamazan Akdemir
Nov 15, 2011·Current Cardiovascular Risk Reports·Taslima Bhuiyan, Mathew S Maurer
Mar 24, 2012·Circulation. Heart Failure·Finlay A McAlisterUNKNOWN Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators
Jul 19, 2012·Circulation·Loek van HeerebeekWalter J Paulus
Aug 14, 2012·European Heart Journal·Marco MetraAdriaan A Voors
Aug 31, 2012·Lancet·Scott D SolomonUNKNOWN Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investig

❮ Previous
Next ❯

Citations

Aug 1, 2019·Heart Failure Reviews·Sadi Loai, Hai-Ling Margaret Cheng
Nov 20, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Adrian CovicMehmet Kanbay
Jul 27, 2021·Frontiers in Physiology·Gustavo Jose Justo da SilvaAlessandro Cataliotti
Oct 17, 2017·Advances in Chronic Kidney Disease·David H Ellison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
Sarinya PuwanantKrishnaswamy Chandrasekaran
© 2022 Meta ULC. All rights reserved